Small Cell Lung Cancer: 177Lu-EVG321 Treatment

We are testing a new drug to see if it is safe and how well the body tolerates it in patients with small cell lung cancer. This study aims to gather important information for future treatments.

>2 yearsSafety phase (I)OncologyPulmonology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Medizinische Universitaet Innsbruck
University Hospital for Nuclear Medicine
Innsbruck, Austria
Azienda Socio Sanitaria Territoriale Papa Giovanni Xxiii
Medicine and Surgery
Treviolo, Italy
Sponsor: Evergreen Theragnostics Inc.
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.